KOA SHOJI HOLDINGS CO.,LTD. Logo

KOA SHOJI HOLDINGS CO.,LTD.

Imports APIs and manufactures generic drugs for Japan's pharmaceutical industry.

9273 | T

Overview

Corporate Details

ISIN(s):
JP3283420002
LEI:
Country:
Japan
Address:
横浜市港北区日吉七丁目13−15
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

KOA SHOJI HOLDINGS CO., LTD. is a pharmaceutical holding group operating a dual business model that combines a trading company and a manufacturer. The group specializes in supporting the pharmaceutical industry "from upstream" by importing and distributing high-quality, safe, and reliable Active Pharmaceutical Ingredients (APIs) for the Japanese market. In addition to its core trading activities, the company also manufactures and sells generic drugs. Its integrated operations, which include contract manufacturing and packaging services, aim to provide a stable supply chain for its customers and address the healthcare needs of an aging society.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-29 06:00
Registration Form
確認書
Japanese 8.2 KB
2025-09-29 06:00
Annual Report
有価証券報告書-第11期(2024/07/01-2025/06/30)
Japanese 1.5 MB
2025-06-20 03:20
Earnings Release
臨時報告書
Japanese 18.4 KB
2025-02-13 05:00
Interim Report
半期報告書-第11期(2024/07/01-2025/06/30)
Japanese 191.9 KB
2025-02-13 05:00
Report Publication Announcement
確認書
Japanese 8.1 KB
2024-09-30 08:27
Post-Annual General Meeting Information
臨時報告書
Japanese 24.6 KB
2024-09-30 08:26
Governance Information
内部統制報告書-第10期(2023/07/01-2024/06/30)
Japanese 23.4 KB
2024-09-30 08:26
Registration Form
確認書
Japanese 8.1 KB
2024-09-30 08:25
Annual Report
有価証券報告書-第10期(2023/07/01-2024/06/30)
Japanese 1.5 MB
2024-06-26 08:25
Earnings Release
臨時報告書
Japanese 18.4 KB
2024-06-05 09:30
Registration Form
訂正有価証券届出書(参照方式)
Japanese 86.2 KB
2024-06-05 09:30
Registration Form
訂正有価証券届出書(参照方式)
Japanese 171.1 KB
2024-05-27 08:00
Registration Form
有価証券届出書(参照方式)
Japanese 101.1 KB
2024-05-27 08:00
Registration Form
有価証券届出書(参照方式)
Japanese 250.3 KB
2024-05-13 08:30
Report Publication Announcement
確認書
Japanese 8.1 KB

Automate Your Workflow. Get a real-time feed of all KOA SHOJI HOLDINGS CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for KOA SHOJI HOLDINGS CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for KOA SHOJI HOLDINGS CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Adlai Nortye Ltd. Logo
Clinical-stage biopharma developing innovative targeted and immuno-oncology therapies.
United States of America
ANL
ADMA BIOLOGICS, INC. Logo
End-to-end biopharma making plasma-derived biologics for immune-compromised patients.
United States of America
ADMA
Adverum Biotechnologies, Inc. Logo
Developing single-injection gene therapies for prevalent ocular diseases like wet AMD.
United States of America
ADVM
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France
ALDVI
AegirBio AB Logo
Develops user-friendly, saliva-based tests for health monitoring & therapeutic drug monitoring.
Sweden
AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France
AELIS
AEON Biopharma, Inc. Logo
Developing therapeutic neurotoxins for medical conditions like migraines and cervical dystonia.
United States of America
AEON
AFC-HD AMS Life Science Co.,Ltd. Logo
An OEM of health foods, supplements, and cosmetics, managing the full value chain from R&D to sales.
Japan
2927
AGENUS INC Logo
Develops antibodies, cell therapies & adjuvants to harness the immune system against cancer.
United States of America
AGEN
AGIOS PHARMACEUTICALS, INC. Logo
Pioneering cellular metabolism therapies for rare, genetically defined diseases like anemias.
United States of America
AGIO

Talk to a Data Expert

Have a question? We'll get back to you promptly.